
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
cerberus CRISPR/Cas9 KO Plasmid (h) | sc-417362 | 20 µg | $397.00 |
CER1 encodes cerberus, a secreted antagonist of key morphogen pathways that binds and inhibits members of the BMP, NODAL/TGF-β, and WNT families to modulate extracellular signaling gradients. Through these interactions, cerberus contributes to embryonic patterning decisions, including mesendoderm specification and anterior neural development, by constraining SMAD- and β-catenin–dependent transcriptional programs. Dysregulated CER1 expression has been reported in contexts involving aberrant differentiation, epithelial–mesenchymal transition, and altered growth factor signaling, making it relevant to studies of developmental disorders and oncogenic pathway rewiring. As a secreted regulator, CER1 is also useful for interrogating paracrine control of cell fate in stem cell differentiation and organoid models.
cerberus CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the CER1 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the CER1 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the CER1 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish cerberus protein expression.
This CRISPR knockout system enables efficient generation of CER1-deficient cell models for investigation of cerberus signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.